News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,234 Results
Type
Article (37061)
Company Profile (18)
Press Release (221155)
Multimedia
Podcasts (4)
Webinars (9)
Section
Business (71406)
Career Advice (456)
Deals (7095)
Drug Delivery (13)
Drug Development (32235)
Employer Resources (39)
FDA (6518)
Job Trends (5085)
News (116294)
Policy (8545)
Tag
2024 Biotech Bay Standard (2)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
Academia (2613)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (28)
Alliances (17300)
ALS (37)
Alzheimer's disease (616)
Antibody-drug conjugate (ADC) (22)
Approvals (6549)
Artificial intelligence (75)
Autoimmune disease (2)
Automation (5)
Bankruptcy (41)
Best Places to Work (4393)
BIOSECURE Act (3)
Biosimilars (16)
Biotechnology (15)
Bladder cancer (27)
Brain cancer (9)
Breast cancer (104)
Cancer (777)
Cardiovascular disease (85)
Career advice (422)
Career pathing (10)
CAR-T (48)
Cell therapy (135)
Cervical cancer (7)
Clinical research (25456)
Collaboration (219)
Compensation (10)
Complete response letters (2)
COVID-19 (1822)
CRISPR (14)
C-suite (152)
Cystic fibrosis (31)
Data (960)
Decentralized trials (1)
Denatured (3)
Depression (12)
Diabetes (81)
Diagnostics (2760)
Digital health (6)
Diversity (5)
Diversity, equity & inclusion (14)
Drug discovery (29)
Drug pricing (19)
Drug shortages (2)
Duchenne muscular dystrophy (27)
Earnings (14482)
Editorial (5)
Employer branding (3)
Employer resources (36)
Events (26795)
Executive appointments (495)
FDA (6934)
Featured Employer (6)
Frontotemporal dementia (4)
Funding (262)
Gene editing (39)
Generative AI (7)
Gene therapy (106)
GLP-1 (169)
Government (1817)
Guidances (10)
Healthcare (9007)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (16)
Indications (10)
Infectious disease (1894)
Inflammatory bowel disease (53)
Inflation Reduction Act (2)
Influenza (28)
Intellectual property (21)
Interviews (46)
IPO (3008)
IRA (7)
Job creations (808)
Job search strategy (395)
Kidney cancer (5)
Labor market (6)
Layoffs (55)
Leadership (2)
Legal (1337)
Liver cancer (29)
Lung cancer (107)
Lymphoma (60)
Machine learning (2)
Management (12)
Manufacturing (52)
MASH (24)
Medical device (6059)
Medtech (6060)
Mergers & acquisitions (4184)
Metabolic disorders (166)
Multiple sclerosis (29)
NASH (5)
Neurodegenerative disease (29)
Neuropsychiatric disorders (1)
Neuroscience (783)
NextGen: Class of 2025 (3045)
Non-profit (2547)
Northern California (792)
Now hiring (4)
Obesity (61)
Opinion (43)
Ovarian cancer (32)
Pain (20)
Pancreatic cancer (28)
Parkinson's disease (43)
Partnered (4)
Patents (54)
Patient recruitment (54)
Peanut (18)
People (35362)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase I (7603)
Phase II (11389)
Phase III (8452)
Pipeline (301)
Policy (24)
Postmarket research (1365)
Preclinical (3533)
Press Release (26)
Prostate cancer (32)
Psychedelics (8)
Radiopharmaceuticals (87)
Rare diseases (121)
Real estate (1845)
Recruiting (17)
Regulatory (6110)
Reports (8)
Research institute (1668)
Resumes & cover letters (33)
Rett syndrome (3)
RNA editing (1)
RSV (25)
Schizophrenia (15)
Series A (40)
Series B (29)
Service/supplier (1)
Sickle cell disease (27)
Southern California (629)
Spinal muscular atrophy (54)
Sponsored (8)
Startups (1423)
Stomach cancer (2)
Supply chain (6)
Tariffs (3)
The Weekly (1)
United States (6890)
Vaccines (339)
Venture capitalists (1)
Weight loss (30)
Women's health (6)
Worklife (3)
Date
Today (67)
Last 7 days (273)
Last 30 days (822)
Last 365 days (10187)
2025 (3029)
2024 (10871)
2023 (13369)
2022 (20697)
2021 (22385)
2020 (22056)
2019 (19091)
2018 (14239)
2017 (12392)
2016 (12456)
2015 (14211)
2014 (10756)
2013 (10208)
2012 (10425)
2011 (10679)
2010 (9579)
Location
Africa (344)
Alabama (15)
Alaska (3)
Arizona (70)
Arkansas (9)
Asia (15573)
Australia (3289)
California (1699)
Canada (568)
China (143)
Colorado (101)
Connecticut (82)
Delaware (42)
Europe (37245)
Florida (306)
Georgia (76)
Idaho (20)
Illinois (224)
India (7)
Indiana (93)
Iowa (2)
Japan (60)
Kansas (23)
Kentucky (13)
Louisiana (5)
Maine (17)
Maryland (240)
Massachusetts (1149)
Michigan (55)
Minnesota (119)
Mississippi (1)
Missouri (31)
Montana (16)
Nebraska (7)
Nevada (21)
New Hampshire (22)
New Jersey (580)
New Mexico (16)
New York (514)
North Carolina (407)
North Dakota (3)
Northern California (792)
Ohio (81)
Oklahoma (5)
Oregon (11)
Pennsylvania (373)
Puerto Rico (1)
Rhode Island (12)
South America (445)
South Carolina (13)
Southern California (629)
Tennessee (69)
Texas (275)
Utah (57)
Virginia (49)
Washington D.C. (19)
Washington State (164)
West Virginia (2)
Wisconsin (14)
258,234 Results for "karolinska university hospital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
XNK Therapeutics enters into research collaboration with Karolinska University Hospital in acute myeloid leukemia (AML)
XNK Therapeutics AB announced that the company has entered into a research collaboration with the Karolinska University Hospital, Sweden, to evaluate the suitability of the company’s autologous natural killer cell therapy candidate XNK02 as a novel therapy for treatment of acute myeloid leukemia.
August 24, 2023
·
3 min read
Press Releases
University Hospitals Cleveland Medical Center Activates AI for Early Lung Cancer Identification
April 2, 2025
·
4 min read
Press Releases
University Medical Centre Ljubljana and University Hospital of Maribor Elevate Antimicrobial Stewardship with DoseMeRx
January 15, 2025
·
3 min read
Press Releases
Novotech Partners with Kyungpook National University Hospital to Strengthen Clinical Trial Capabilities in South Korea
March 19, 2025
·
4 min read
Press Releases
Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals
January 27, 2025
·
2 min read
Genetown
Alzheon CEO Dr. Martin Tolar to Present ALZ-801/Valiltramiprosate Investigational Oral Alzheimer’s Treatment Program at Nobel Forum at Karolinska Institute in Stockholm, Sweden
Alzheon, Inc. announced its participation in the Nobel Forum “Challenges for Implementation of New Alzheimer’s Disease Treatments” covering Alzheimer’s therapeutics for the future, at the Karolinska Institute in Stockholm, Sweden from January 18-19.
January 3, 2024
·
7 min read
Press Releases
Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital
February 24, 2025
·
5 min read
BioMidwest
Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
Accuray Incorporated announced that long-term customer Heidelberg University Hospital in Heidelberg, Germany, has selected the company’s Radixact® System, equipped with its proprietary ClearRT®, Synchrony® and VOLO™ Ultra Optimizer solutions, to help transform their approach to cancer care.
June 27, 2024
·
5 min read
Business
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
Evotec SE announced that the Company entered a partnership with Inserm, the French National Institute of Health and Medical Research, Lille University Hospital and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases.
May 30, 2024
·
11 min read
1 of 25,824
Next
